ClinConnect ClinConnect Logo
Search / Trial NCT05235945

The Effect of Exercise in Patients Awaiting Bariatric Surgery

Launched by UNIVERSITY COLLEGE, LONDON · Feb 1, 2022

Trial Information

Current as of July 22, 2025

Recruiting

Keywords

Exercise Fitness Pre Operative Prehabilitation Bariatric Obesity Surgery

ClinConnect Summary

This clinical trial is studying how a four-week exercise program can affect patients who are waiting for bariatric surgery, which is a type of weight-loss surgery. Researchers want to see if exercising before the surgery can improve fitness levels, metabolic rate (how quickly your body uses energy), and body weight, both before and after the surgery. The trial is taking place at several hospitals, including UCLH, and is currently looking for participants.

To join this study, you need to be an adult aged 18 or older and enrolled in a bariatric surgery program with a body mass index (BMI) over 30. It’s also important that your weight hasn’t changed significantly in the last three months, and you should be able to follow the study rules. If you decide to participate, you will take part in supervised exercise sessions and will have your fitness, weight, and strength measured before and after the program. Additionally, you may be asked about your experience in the study, which could help with future research.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • 1. Adults, aged 18 and above.
  • 2. Patients enrolled in the UCLH, Homerton or Whittington Hospitals bariatric surgery program with BMI \> 30 kg/m2
  • 3. ≤5 % variation in body weight over preceding 3 months.
  • 4. Willing and able to comply with the trial protocol.
  • 5. Willing and able to provide written informed consent
  • 6. Male or Female
  • Exclusion Criteria:
  • 1. Pregnant or lactating mothers.
  • 2. Weight over 180 kg (due to weight restrictions of equipment used).
  • 3. Current use of betablockade.
  • 4. Concurrent participation in other clinical intervention trial.
  • 5. Clinically significant medical co-morbidities (e.g. uncontrolled hypertension, unstable cardiovascular disease) that could place at risk of an adverse response to exercise.
  • 6. History of atrial fibrillation, unstable angina, acute coronary syndrome, congestive heart failure New York Heart Association class III-IV within the preceding 12 months.

About University College, London

University College London (UCL) is a leading global research institution renowned for its commitment to advancing healthcare through innovative clinical trials. As a prominent sponsor of clinical research, UCL leverages its multidisciplinary expertise and state-of-the-art facilities to conduct rigorous investigations aimed at improving patient outcomes and addressing pressing medical challenges. The institution fosters collaboration among researchers, healthcare professionals, and industry partners, ensuring that its trials adhere to the highest ethical standards and regulatory guidelines. UCL's dedication to translating scientific discoveries into practical applications underscores its role as a vital contributor to the advancement of medical science and public health.

Locations

London, , United Kingdom

Patients applied

0 patients applied

Trial Officials

Belinda Durey

Principal Investigator

UCL, UniSA and UNSW

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials